“The departure of Scott Gottlieb from the U.S. Food and Drug Administration on Tuesday is a potential blow to Silicon Valley.
In his two years as commissioner of the FDA, Gottlieb, a doctor and former venture capitalist, gained a reputation as a proponent of health-care innovation, including pharmaceutical companies bringing new drugs to market.
He helped to establish a digital health software program called Pre-Cert to provide a way for tech companies like Apple and Samsung to get quicker approval for low-risk health products. Last September, Apple received clearance to market an electrocardiogram app and sensor on its Apple Watch, the company’s biggest move into the health-care market.
Gottlieb issued a statement at the time to encourage Apple and other tech companies to push into health care, especially if they could help consumers engage more proactively with their health.
“Scott did a lot culturally to make the agency easier to work with,” said Bob Kocher, a partner at venture capital firm Venrock, investing in health-technology. “I think he’ll be missed by many in the tech industry, including the start-ups.”’
Newt’s guest is David Trulio, President and CEO of the Ronald Reagan Presidential Foundation and Institute. They discuss the 35th anniversary of the fall of…
Tomorrow the House Ethic Committee is expected to discuss the fate of its report on Matt Gaetz, President-elect Trump’s choice for attorney general. The former Florida…